Contract HHSF223201400071P
Neogen Corp · Department Of Health And Human Services · January 27, 2014
Neogen Corp was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on January 27, 2014 for $9,000 of work in biological product (except diagnostic) manufacturing. Performance is in Lansing, MI. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- HHSF223201400071P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Lansing, MI
- First action
- January 27, 2014
Description
IGF::OT::IGF VERATOX SOY DETECTION KITS
Modification timeline
-
January 27, 2014Base award$9.4K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSF223201400071P?
Contract HHSF223201400071P is a federal contract awarded to Neogen Corp by Department Of Health And Human Services on January 27, 2014 for $9,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 0 times since the base award.
Who won contract HHSF223201400071P?
Neogen Corp won contract HHSF223201400071P from Department Of Health And Human Services.
How much is contract HHSF223201400071P worth?
Contract HHSF223201400071P has obligated $9,000 to date.